The prevalence of serological markers for hepatitis-B infection was investigated in patients affected by insulin-dependent diabetes (IDDM) living in different Italian regions and in the London area of the UK. Thirty five percent of Italian and 13% of British patients showed positive markers for hepatitis-B infection but none was found to be HBsAg carrier positive. When these results are compared with data observed in control populations in both countries, these findings suggest a higher prevalence of hepatitis-B infection in patients with IDDM. However, the negativity for HbsAg indicates that diabetic patients infected by the hepatitis-B virus have an effective capacity for clearance of HBsAg.
Prevalence of serological markers for hepatitis-B in patients with insulin-dependent diabetes / P. Pozzilli, S. Pagani, R. Buzzetti, L. Cruciani, P.E. Beales, D. Cucinotta, L. Benzi, M. Porta, L. Biasio, A. Zanetti, E. Tanzi, D. Andreani. - In: Practical diabetes international. - ISSN 1528-252X. - 8:1(1991 Jan), pp. 5-6. [10.1002/pdi.1960080103]
Prevalence of serological markers for hepatitis-B in patients with insulin-dependent diabetes
E. TanziPenultimo
;
1991
Abstract
The prevalence of serological markers for hepatitis-B infection was investigated in patients affected by insulin-dependent diabetes (IDDM) living in different Italian regions and in the London area of the UK. Thirty five percent of Italian and 13% of British patients showed positive markers for hepatitis-B infection but none was found to be HBsAg carrier positive. When these results are compared with data observed in control populations in both countries, these findings suggest a higher prevalence of hepatitis-B infection in patients with IDDM. However, the negativity for HbsAg indicates that diabetic patients infected by the hepatitis-B virus have an effective capacity for clearance of HBsAg.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.